# Zoledronic Acid

## Aclasta inj 5mg/100mL

| TAH Drug Code      | [IACL](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IACL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment and prevention of postmenopausal osteoporosis. Treatment to increase bone mass in men with osteoporosis. Treatment and prevention of glucocorticoid-induced osteoporosis. Treatment of Paget’s disease of bone in men and women.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | IVD, 5 mg once every year.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Hypocalcemia. Patients with creatinine clearance less than 35 mL/min and in those with evidence of acute renal impairment. Hypersensitivity to any component of Aclasta.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | Common: Peripheral edema (Paget disease, 3%; osteoporosis, 4.6-5.5%; osteopenia, 3.9-5.6%; hypercalcemia of malignancy, 5-<10%; bone metastasis, 21%), Weight decreased (bone metastasis, 16%), Abdominal pain (osteoporosis (female), 0.9-4.6%; osteoporosis (male), 7.9%; osteoporosis (male and female), 7.5%; osteopenia, 6.6-8.6%; Paget disease, 2%; hypercalcemia of malignancy, 16%; bone metastasis, 14%), Constipation (Paget disease, 6%; hypercalcemia of malignancy, 27%), Diarrhea (osteoporosis, 5.2-6%; osteopenia, 6.6-8.1%; Paget disease, 6%; hypercalcemia of malignancy, 17%; bone metastasis, 24%), Loss of appetite (osteoporosis, 1-2%; osteopenia, 0.6-2%; Paget disease, 2%; hypercalcemia of malignancy, 9%; bone metastasis, 22%), Nausea (osteoporosis (female), 4.5-8.5%; osteoporosis (male and female), 9.6%; osteopenia, 11.6-17.7%; Paget disease, 9%; hypercalcemia of malignancy, 29%; bone metastasis, 46%), Vomiting (Paget disease, 2%; osteoporosis, 3.4-4.6%; osteopenia, 5-7.6%; hypercalcemia of malignancy, 14%; bone metastasis, 32%), Arthralgia (Osteoporosis (female), 17.9-23.8%, (acute phase, 3-7%); osteoporosis (male, acute phase), 11.1%; osteopenia, 18.8-27.3%, (acute phase, 6.1%); hypercalcemia of malignancy, 5-<10%; Paget disease, 9%; bone metastasis, 21%), Backache (Osteoporosis (male and female), 4.3%; osteoporosis (male, acute phase), 3.3%; osteopenia, 16.6-18.2%, (acute phase, 1.7%); Paget disease, 4%; bone metastasis, 15%), Pain in limb (Osteoporosis (female), 5.9-11.3%; osteoporosis (male and female), 3.1%; osteopenia, 11.1-16%, (acute phase, 3.9%); bone metastasis, 14%), Asthenia (osteoporosis, 3.2 to 5.3%; osteopenia, 2.8-6.1%; Paget disease, 2%; hypercalcemia of malignancy, 5-<10%; bone metastasis, 24%), Dizziness (osteoporosis, 2-7.6%; osteopenia, 6.1-7.6%; Paget disease, 9%; bone metastasis, 18%), Headache (osteoporosis (female), 3.9-12.4%, (acute phase, 7%); osteoporosis (male), 15%, (acute phase, 9.8%); osteopenia, 14.6-20.4%, (acute phase, 13.3%); Paget disease, 11%; hypercalcemia of malignancy, 5-<10%; bone metastasis, 19%), Insomnia (hypercalcemia of malignancy, 15%; bone metastasis, 16%), Paresthesia (Paget disease, 2%; bone metastasis, 15% .), Nephrotoxicity (bone metastasis, 11-17%), Fatigue (osteoporosis (female), 2.1-5.4%; osteoporosis (male), 17.6%, (acute phase, 12.4%); osteopenia, 9.9-14.6%, (acute phase, 8.3%); Paget disease, 8%; bone metastasis, 39%), Fever (osteoporosis (female, acute phase), 7-18%; osteoporosis (male, acute phase), 15.7%; osteopenia, 21-21.7% (acute phase, 19.3%); Paget disease, 3-11%; hypercalcemia of malignancy (acute phase), 44%; bone metastasis, 32%) Serious: Atrial fibrillation (osteoporosis (female), 1.3-2.8%; osteoporosis (male), 3.3%; osteoporosis (male and female), 0.7%), Cardiac dysrhythmia, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Hypocalcemia (Osteoporosis, up to 0.2%; hypercalcemia of malignancy, 5-<10%; bone metastasis, 1.3%; Paget disease, 3-21%), Bone pain (Osteoporosis (female), 3.2-5.8%; osteoporosis (male and female), 3.1%; osteopenia, 3.3-5.1%; Paget disease, 9%; hypercalcemia of malignancy, 12%; bone metastasis, 55%), Myalgia (Osteoporosis (female), 4.9-11.7%, (acute phase, 9%); osteoporosis (male), 19.6%, (acute phase, 17.1%); osteopenia, 19.2-22.7%; Paget disease, 7%; bone metastasis, 23%), Necrosis of bone, acute, Osteonecrosis of jaw, Tetany, Cerebrovascular accident (osteoporosis, 2.3%), Numbness, Seizure, Nephrotoxic acute renal failure, Serum creatinine above reference range (osteoporosis, 1.2-2.1%; bone metastasis, 1%; hypercalcemia of malignancy, 2%), Dyspnea (Paget disease, 5%; osteoporosis (male), 6.5%; hypercalcemia of malignancy, 22%; bone metastasis, 27%) |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/zoledronic-acid-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

## Bolenic IV infusion 4mg

| TAH Drug Code      | [IBOL](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IBOL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumor-induced hypercalcemia) in patients with advanced malignancies involving bone. Treatment of hypercalcemia of malignancy (HCM).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Dosing             | IVD, 4 mg once every 3-4 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Known hypersensitivity to zoledronic acid or other bisphosphonates.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Adverse Effects    | Common: Peripheral edema (Paget disease, 3%; osteoporosis, 4.6-5.5%; osteopenia, 3.9-5.6%; hypercalcemia of malignancy, 5-<10%; bone metastasis, 21%), Weight decreased (bone metastasis, 16%), Abdominal pain (osteoporosis (female), 0.9-4.6%; osteoporosis (male), 7.9%; osteoporosis (male and female), 7.5%; osteopenia, 6.6-8.6%; Paget disease, 2%; hypercalcemia of malignancy, 16%; bone metastasis, 14%), Constipation (Paget disease, 6%; hypercalcemia of malignancy, 27%), Diarrhea (osteoporosis, 5.2-6%; osteopenia, 6.6-8.1%; Paget disease, 6%; hypercalcemia of malignancy, 17%; bone metastasis, 24%), Loss of appetite (osteoporosis, 1-2%; osteopenia, 0.6-2%; Paget disease, 2%; hypercalcemia of malignancy, 9%; bone metastasis, 22%), Nausea (osteoporosis (female), 4.5-8.5%; osteoporosis (male and female), 9.6%; osteopenia, 11.6-17.7%; Paget disease, 9%; hypercalcemia of malignancy, 29%; bone metastasis, 46%), Vomiting (Paget disease, 2%; osteoporosis, 3.4-4.6%; osteopenia, 5-7.6%; hypercalcemia of malignancy, 14%; bone metastasis, 32%), Arthralgia (Osteoporosis (female), 17.9-23.8%, (acute phase, 3-7%); osteoporosis (male, acute phase), 11.1%; osteopenia, 18.8-27.3%, (acute phase, 6.1%); hypercalcemia of malignancy, 5-<10%; Paget disease, 9%; bone metastasis, 21%), Backache (Osteoporosis (male and female), 4.3%; osteoporosis (male, acute phase), 3.3%; osteopenia, 16.6-18.2%, (acute phase, 1.7%); Paget disease, 4%; bone metastasis, 15%), Pain in limb (Osteoporosis (female), 5.9-11.3%; osteoporosis (male and female), 3.1%; osteopenia, 11.1-16%, (acute phase, 3.9%); bone metastasis, 14%), Asthenia (osteoporosis, 3.2 to 5.3%; osteopenia, 2.8-6.1%; Paget disease, 2%; hypercalcemia of malignancy, 5-<10%; bone metastasis, 24%), Dizziness (osteoporosis, 2-7.6%; osteopenia, 6.1-7.6%; Paget disease, 9%; bone metastasis, 18%), Headache (osteoporosis (female), 3.9-12.4%, (acute phase, 7%); osteoporosis (male), 15%, (acute phase, 9.8%); osteopenia, 14.6-20.4%, (acute phase, 13.3%); Paget disease, 11%; hypercalcemia of malignancy, 5-<10%; bone metastasis, 19%), Insomnia (hypercalcemia of malignancy, 15%; bone metastasis, 16%), Paresthesia (Paget disease, 2%; bone metastasis, 15% .), Nephrotoxicity (bone metastasis, 11-17%), Fatigue (osteoporosis (female), 2.1-5.4%; osteoporosis (male), 17.6%, (acute phase, 12.4%); osteopenia, 9.9-14.6%, (acute phase, 8.3%); Paget disease, 8%; bone metastasis, 39%), Fever (osteoporosis (female, acute phase), 7-18%; osteoporosis (male, acute phase), 15.7%; osteopenia, 21-21.7% (acute phase, 19.3%); Paget disease, 3-11%; hypercalcemia of malignancy (acute phase), 44%; bone metastasis, 32%) Serious: Atrial fibrillation (osteoporosis (female), 1.3-2.8%; osteoporosis (male), 3.3%; osteoporosis (male and female), 0.7%), Cardiac dysrhythmia, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Hypocalcemia (Osteoporosis, up to 0.2%; hypercalcemia of malignancy, 5-<10%; bone metastasis, 1.3%; Paget disease, 3-21%), Bone pain (Osteoporosis (female), 3.2-5.8%; osteoporosis (male and female), 3.1%; osteopenia, 3.3-5.1%; Paget disease, 9%; hypercalcemia of malignancy, 12%; bone metastasis, 55%), Myalgia (Osteoporosis (female), 4.9-11.7%, (acute phase, 9%); osteoporosis (male), 19.6%, (acute phase, 17.1%); osteopenia, 19.2-22.7%; Paget disease, 7%; bone metastasis, 23%), Necrosis of bone, acute, Osteonecrosis of jaw, Tetany, Cerebrovascular accident (osteoporosis, 2.3%), Numbness, Seizure, Nephrotoxic acute renal failure, Serum creatinine above reference range (osteoporosis, 1.2-2.1%; bone metastasis, 1%; hypercalcemia of malignancy, 2%), Dyspnea (Paget disease, 5%; osteoporosis (male), 6.5%; hypercalcemia of malignancy, 22%; bone metastasis, 27%) |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/zoledronic-acid-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

